Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Roth

Showing results (221-230 of 396) with videos related to

Pageof 40
Sort By:
Sleep|September 16, 2008
Low-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night (MOTN) awakeningsThomas Roth, Steven G Hull, D Alan Lankford, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|October 16, 2014
A randomized, double-blind, placebo-controlled, multicenter, 28-day, polysomnographic study of gabapentin in transient insomnia induced by sleep phase advanceSandy A Furey, Steven G Hull, Mark T Leibowitz, et al.
Archiv Der Pharmazie|June 12, 2014
Synthesis, cytotoxic, and antitumor activities of 2-pyridylhydrazones derived from 3-benzoylpyridazinesJohnny Easmon, Gerhard Pürstinger, Gottfried Heinisch, et al.
Neuroimage|August 22, 2012
Connectivity analysis of novelty process in habitual short sleepersAbbas Babajani-Feremi, Valentina Gumenyuk, Thomas Roth, et al.
Clinical Therapeutics|August 17, 2024
Weight Loss With Once-nightly Sodium Oxybate for the Treatment of Narcolepsy: Analysis From the Phase III Randomized study Evaluating the efficacy and SafeTy of a ONce nightly formulation of sodium oxybate (REST-ON) TrialThomas Roth, Anne Marie Morse, Richard Bogan, et al.
Sleep|March 5, 2016
Prevalence and Predictors of Prescription Sleep Aid Use among Individuals with DSM-5 Insomnia: The Role of HyperarousalVivek Pillai, Philip Cheng, David A Kalmbach, et al.
Journal of Synchrotron Radiation|March 11, 2020
X-ray optics and beam characterization using random modulation: experimentsSebastien Berujon, Ruxandra Cojocaru, Pierre Piault, et al.
Current Drug Safety|December 2, 2011
Zopiclone as positive control in studies examining the residual effects of hypnotic drugs on driving abilityJoris C Verster, D Warren Spence, Azmeh Shahid, et al.
Human Psychopharmacology|June 10, 2014
A single-dose, randomized, double-blind, double dummy, placebo and positive-controlled, five-way cross-over study to assess the pharmacodynamic effects of lorediplon in a phase advance model of insomnia in healthy Caucasian adult male subjectsLucy Horoszok, Thais Baleeiro, Fabiana D'Aniello, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|May 1, 2020
Efficacy and safety of esmirtazapine in adult outpatients with chronic primary insomnia: a randomized, double-blind placebo-controlled study and open-label extensionNeely Ivgy-May, Goeran Hajak, Gonnie van Osta, et al.
Pageof 40

Showing results (221-230 of 396) with videos related to

Sort By:
Pageof 40
Sleep|September 16, 2008
Low-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night (MOTN) awakeningsThomas Roth, Steven G Hull, D Alan Lankford, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|October 16, 2014
A randomized, double-blind, placebo-controlled, multicenter, 28-day, polysomnographic study of gabapentin in transient insomnia induced by sleep phase advanceSandy A Furey, Steven G Hull, Mark T Leibowitz, et al.
Archiv Der Pharmazie|June 12, 2014
Synthesis, cytotoxic, and antitumor activities of 2-pyridylhydrazones derived from 3-benzoylpyridazinesJohnny Easmon, Gerhard Pürstinger, Gottfried Heinisch, et al.
Neuroimage|August 22, 2012
Connectivity analysis of novelty process in habitual short sleepersAbbas Babajani-Feremi, Valentina Gumenyuk, Thomas Roth, et al.
Clinical Therapeutics|August 17, 2024
Weight Loss With Once-nightly Sodium Oxybate for the Treatment of Narcolepsy: Analysis From the Phase III Randomized study Evaluating the efficacy and SafeTy of a ONce nightly formulation of sodium oxybate (REST-ON) TrialThomas Roth, Anne Marie Morse, Richard Bogan, et al.
Sleep|March 5, 2016
Prevalence and Predictors of Prescription Sleep Aid Use among Individuals with DSM-5 Insomnia: The Role of HyperarousalVivek Pillai, Philip Cheng, David A Kalmbach, et al.
Journal of Synchrotron Radiation|March 11, 2020
X-ray optics and beam characterization using random modulation: experimentsSebastien Berujon, Ruxandra Cojocaru, Pierre Piault, et al.
Current Drug Safety|December 2, 2011
Zopiclone as positive control in studies examining the residual effects of hypnotic drugs on driving abilityJoris C Verster, D Warren Spence, Azmeh Shahid, et al.
Human Psychopharmacology|June 10, 2014
A single-dose, randomized, double-blind, double dummy, placebo and positive-controlled, five-way cross-over study to assess the pharmacodynamic effects of lorediplon in a phase advance model of insomnia in healthy Caucasian adult male subjectsLucy Horoszok, Thais Baleeiro, Fabiana D'Aniello, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|May 1, 2020
Efficacy and safety of esmirtazapine in adult outpatients with chronic primary insomnia: a randomized, double-blind placebo-controlled study and open-label extensionNeely Ivgy-May, Goeran Hajak, Gonnie van Osta, et al.
Pageof 40